Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 159

1.

Prostate Cancer National Summit's Call to Action.

Heath EI, Nanus DM, Slovin S, Strand C, Higano C, Simons VH, Johnson C, Kyriakopoulos CE, Reichert ZR, Lory S, George DJ, Mucci LA, Marcus JD, Trendel JA, Bock CH.

Clin Genitourin Cancer. 2019 Jun;17(3):161-168. doi: 10.1016/j.clgc.2019.04.002. Epub 2019 Apr 16. No abstract available.

PMID:
31085057
2.
3.

Insertion sequences drive the emergence of a highly adapted human pathogen.

Sentausa E, Basso P, Berry A, Adrait A, Bellement G, Couté Y, Lory S, Elsen S, Attrée I.

Microb Genom. 2019 Apr 4. doi: 10.1099/mgen.0.000265. [Epub ahead of print]

4.

Inhibition of Pseudomonas aeruginosa and Mycobacterium tuberculosis disulfide bond forming enzymes.

Landeta C, McPartland L, Tran NQ, Meehan BM, Zhang Y, Tanweer Z, Wakabayashi S, Rock J, Kim T, Balasubramanian D, Audette R, Toosky M, Pinkham J, Rubin EJ, Lory S, Pier G, Boyd D, Beckwith J.

Mol Microbiol. 2019 Apr;111(4):918-937. doi: 10.1111/mmi.14185. Epub 2019 Mar 18.

PMID:
30556355
5.

Phage Morons Play an Important Role in Pseudomonas aeruginosa Phenotypes.

Tsao YF, Taylor VL, Kala S, Bondy-Denomy J, Khan AN, Bona D, Cattoir V, Lory S, Davidson AR, Maxwell KL.

J Bacteriol. 2018 Oct 23;200(22). pii: e00189-18. doi: 10.1128/JB.00189-18. Print 2018 Nov 15.

6.

cAMP and Vfr Control Exolysin Expression and Cytotoxicity of Pseudomonas aeruginosa Taxonomic Outliers.

Berry A, Han K, Trouillon J, Robert-Genthon M, Ragno M, Lory S, Attrée I, Elsen S.

J Bacteriol. 2018 May 24;200(12). pii: e00135-18. doi: 10.1128/JB.00135-18. Print 2018 Jun 15.

7.

Probing the sRNA regulatory landscape of P. aeruginosa: post-transcriptional control of determinants of pathogenicity and antibiotic susceptibility.

Zhang YF, Han K, Chandler CE, Tjaden B, Ernst RK, Lory S.

Mol Microbiol. 2017 Dec;106(6):919-937. doi: 10.1111/mmi.13857. Epub 2017 Nov 2.

8.

Complexity of Complement Resistance Factors Expressed by Acinetobacter baumannii Needed for Survival in Human Serum.

Sanchez-Larrayoz AF, Elhosseiny NM, Chevrette MG, Fu Y, Giunta P, Spallanzani RG, Ravi K, Pier GB, Lory S, Maira-Litrán T.

J Immunol. 2017 Oct 15;199(8):2803-2814. doi: 10.4049/jimmunol.1700877. Epub 2017 Aug 30.

9.

Conjugative type IVb pilus recognizes lipopolysaccharide of recipient cells to initiate PAPI-1 pathogenicity island transfer in Pseudomonas aeruginosa.

Hong TP, Carter MQ, Struffi P, Casonato S, Hao Y, Lam JS, Lory S, Jousson O.

BMC Microbiol. 2017 Feb 7;17(1):31. doi: 10.1186/s12866-017-0943-4.

10.

Pseudomonas aeruginosa Pore-Forming Exolysin and Type IV Pili Cooperate To Induce Host Cell Lysis.

Basso P, Ragno M, Elsen S, Reboud E, Golovkine G, Bouillot S, Huber P, Lory S, Faudry E, Attrée I.

MBio. 2017 Jan 24;8(1). pii: e02250-16. doi: 10.1128/mBio.02250-16.

11.

GRIL-seq provides a method for identifying direct targets of bacterial small regulatory RNA by in vivo proximity ligation.

Han K, Tjaden B, Lory S.

Nat Microbiol. 2016 Dec 22;2:16239. doi: 10.1038/nmicrobiol.2016.239.

12.

The secretome of Acinetobacter baumannii ATCC 17978 type II secretion system reveals a novel plasmid encoded phospholipase that could be implicated in lung colonization.

Elhosseiny NM, El-Tayeb OM, Yassin AS, Lory S, Attia AS.

Int J Med Microbiol. 2016 Dec;306(8):633-641. doi: 10.1016/j.ijmm.2016.09.006. Epub 2016 Oct 1.

PMID:
27713027
13.
14.

Use of a mouse model to identify a blood biomarker for IFNγ activity in pediatric secondary hemophagocytic lymphohistiocytosis.

Buatois V, Chatel L, Cons L, Lory S, Richard F, Guilhot F, Johnson Z, Bracaglia C, De Benedetti F, de Min C, Kosco-Vilbois MH, Ferlin WG.

Transl Res. 2017 Feb;180:37-52.e2. doi: 10.1016/j.trsl.2016.07.023. Epub 2016 Aug 4.

PMID:
27559680
15.

Evaluation of Multiple Immunoassay Technology Platforms to Select the Anti-Drug Antibody Assay Exhibiting the Most Appropriate Drug and Target Tolerance.

Collet-Brose J, Couble PJ, Deehan MR, Nelson RJ, Ferlin WG, Lory S.

J Immunol Res. 2016;2016:5069678. doi: 10.1155/2016/5069678. Epub 2016 May 3.

16.

Oxygen-dependent regulation of c-di-GMP synthesis by SadC controls alginate production in Pseudomonas aeruginosa.

Schmidt A, Hammerbacher AS, Bastian M, Nieken KJ, Klockgether J, Merighi M, Lapouge K, Poschgan C, Kölle J, Acharya KR, Ulrich M, Tümmler B, Unden G, Kaever V, Lory S, Haas D, Schwarz S, Döring G.

Environ Microbiol. 2016 Oct;18(10):3390-3402. doi: 10.1111/1462-2920.13208. Epub 2016 Feb 4.

PMID:
26743546
17.

Fitness cost of antibiotic susceptibility during bacterial infection.

Roux D, Danilchanka O, Guillard T, Cattoir V, Aschard H, Fu Y, Angoulvant F, Messika J, Ricard JD, Mekalanos JJ, Lory S, Pier GB, Skurnik D.

Sci Transl Med. 2015 Jul 22;7(297):297ra114. doi: 10.1126/scitranslmed.aab1621.

PMID:
26203082
18.

Residues located on membrane-embedded flexible loops are essential for the second step of the apolipoprotein N-acyltransferase reaction.

Gélis-Jeanvoine S, Lory S, Oberto J, Buddelmeijer N.

Mol Microbiol. 2015 Feb;95(4):692-705. doi: 10.1111/mmi.12897. Epub 2015 Jan 16.

19.

Structural and functional characterization of Pseudomonas aeruginosa global regulator AmpR.

Caille O, Zincke D, Merighi M, Balasubramanian D, Kumari H, Kong KF, Silva-Herzog E, Narasimhan G, Schneper L, Lory S, Mathee K.

J Bacteriol. 2014 Nov;196(22):3890-902. doi: 10.1128/JB.01997-14. Epub 2014 Sep 2.

20.

GPR107, a G-protein-coupled receptor essential for intoxication by Pseudomonas aeruginosa exotoxin A, localizes to the Golgi and is cleaved by furin.

Tafesse FG, Guimaraes CP, Maruyama T, Carette JE, Lory S, Brummelkamp TR, Ploegh HL.

J Biol Chem. 2014 Aug 29;289(35):24005-18. doi: 10.1074/jbc.M114.589275. Epub 2014 Jul 16.

21.

LTQ-XL mass spectrometry proteome analysis expands the Pseudomonas aeruginosa AmpR regulon to include cyclic di-GMP phosphodiesterases and phosphoproteins, and identifies novel open reading frames.

Kumari H, Murugapiran SK, Balasubramanian D, Schneper L, Merighi M, Sarracino D, Lory S, Mathee K.

J Proteomics. 2014 Jan 16;96:328-342. doi: 10.1016/j.jprot.2013.11.018. Epub 2013 Nov 28.

22.

Enhanced in vivo fitness of carbapenem-resistant oprD mutants of Pseudomonas aeruginosa revealed through high-throughput sequencing.

Skurnik D, Roux D, Cattoir V, Danilchanka O, Lu X, Yoder-Himes DR, Han K, Guillard T, Jiang D, Gaultier C, Guerin F, Aschard H, Leclercq R, Mekalanos JJ, Lory S, Pier GB.

Proc Natl Acad Sci U S A. 2013 Dec 17;110(51):20747-52. doi: 10.1073/pnas.1221552110. Epub 2013 Nov 18.

23.

Deep sequencing analyses expands the Pseudomonas aeruginosa AmpR regulon to include small RNA-mediated regulation of iron acquisition, heat shock and oxidative stress response.

Balasubramanian D, Kumari H, Jaric M, Fernandez M, Turner KH, Dove SL, Narasimhan G, Lory S, Mathee K.

Nucleic Acids Res. 2014 Jan;42(2):979-98. doi: 10.1093/nar/gkt942. Epub 2013 Oct 23.

24.

A comprehensive analysis of in vitro and in vivo genetic fitness of Pseudomonas aeruginosa using high-throughput sequencing of transposon libraries.

Skurnik D, Roux D, Aschard H, Cattoir V, Yoder-Himes D, Lory S, Pier GB.

PLoS Pathog. 2013;9(9):e1003582. doi: 10.1371/journal.ppat.1003582. Epub 2013 Sep 5.

25.

Transcriptional response of mucoid Pseudomonas aeruginosa to human respiratory mucus.

Cattoir V, Narasimhan G, Skurnik D, Aschard H, Roux D, Ramphal R, Jyot J, Lory S.

MBio. 2013 Jan 2;3(6):e00410-12. doi: 10.1128/mBio.00410-12.

26.

The single-nucleotide resolution transcriptome of Pseudomonas aeruginosa grown in body temperature.

Wurtzel O, Yoder-Himes DR, Han K, Dandekar AA, Edelheit S, Greenberg EP, Sorek R, Lory S.

PLoS Pathog. 2012 Sep;8(9):e1002945. doi: 10.1371/journal.ppat.1002945. Epub 2012 Sep 27.

27.

Th17-stimulating protein vaccines confer protection against Pseudomonas aeruginosa pneumonia.

Wu W, Huang J, Duan B, Traficante DC, Hong H, Risech M, Lory S, Priebe GP.

Am J Respir Crit Care Med. 2012 Sep 1;186(5):420-7. doi: 10.1164/rccm.201202-0182OC. Epub 2012 Jun 21.

28.

The regulatory repertoire of Pseudomonas aeruginosa AmpC ß-lactamase regulator AmpR includes virulence genes.

Balasubramanian D, Schneper L, Merighi M, Smith R, Narasimhan G, Lory S, Mathee K.

PLoS One. 2012;7(3):e34067. doi: 10.1371/journal.pone.0034067. Epub 2012 Mar 29.

29.

Outer membrane targeting of Pseudomonas aeruginosa proteins shows variable dependence on the components of Bam and Lol machineries.

Hoang HH, Nickerson NN, Lee VT, Kazimirova A, Chami M, Pugsley AP, Lory S.

MBio. 2011 Dec 6;2(6). pii: e00246-11. doi: 10.1128/mBio.00246-11. Print 2011.

30.

The Chlamydia effector chlamydial outer protein N (CopN) sequesters tubulin and prevents microtubule assembly.

Archuleta TL, Du Y, English CA, Lory S, Lesser C, Ohi MD, Ohi R, Spiller BW.

J Biol Chem. 2011 Sep 30;286(39):33992-8. doi: 10.1074/jbc.M111.258426. Epub 2011 Aug 13.

31.

Utility of in vivo transcription profiling for identifying Pseudomonas aeruginosa genes needed for gastrointestinal colonization and dissemination.

Koh AY, Mikkelsen PJ, Smith RS, Coggshall KT, Kamei A, Givskov M, Lory S, Pier GB.

PLoS One. 2010 Dec 10;5(12):e15131. doi: 10.1371/journal.pone.0015131.

32.

Emergence of Pseudomonas aeruginosa strains producing high levels of persister cells in patients with cystic fibrosis.

Mulcahy LR, Burns JL, Lory S, Lewis K.

J Bacteriol. 2010 Dec;192(23):6191-9. doi: 10.1128/JB.01651-09. Epub 2010 Oct 8.

33.

Phylogenetic and metabolic diversity of bacteria associated with cystic fibrosis.

Guss AM, Roeselers G, Newton IL, Young CR, Klepac-Ceraj V, Lory S, Cavanaugh CM.

ISME J. 2011 Jan;5(1):20-9. doi: 10.1038/ismej.2010.88. Epub 2010 Jul 15.

34.

The Pseudomonas aeruginosa pathogenicity island PAPI-1 is transferred via a novel type IV pilus.

Carter MQ, Chen J, Lory S.

J Bacteriol. 2010 Jul;192(13):3249-58. doi: 10.1128/JB.00041-10. Epub 2010 Apr 2.

35.

Quorum-sensing regulation of a copper toxicity system in Pseudomonas aeruginosa.

Thaden JT, Lory S, Gardner TS.

J Bacteriol. 2010 May;192(10):2557-68. doi: 10.1128/JB.01528-09. Epub 2010 Mar 16.

36.

Relationship between cystic fibrosis respiratory tract bacterial communities and age, genotype, antibiotics and Pseudomonas aeruginosa.

Klepac-Ceraj V, Lemon KP, Martin TR, Allgaier M, Kembel SW, Knapp AA, Lory S, Brodie EL, Lynch SV, Bohannan BJ, Green JL, Maurer BA, Kolter R.

Environ Microbiol. 2010 May;12(5):1293-303. doi: 10.1111/j.1462-2920.2010.02173.x. Epub 2010 Feb 23.

PMID:
20192960
37.

Discovery and characterization of inhibitors of Pseudomonas aeruginosa type III secretion.

Aiello D, Williams JD, Majgier-Baranowska H, Patel I, Peet NP, Huang J, Lory S, Bowlin TL, Moir DT.

Antimicrob Agents Chemother. 2010 May;54(5):1988-99. doi: 10.1128/AAC.01598-09. Epub 2010 Feb 22.

38.

The two-component sensor response regulator RoxS/RoxR plays a role in Pseudomonas aeruginosa interactions with airway epithelial cells.

Hurley BP, Goodman AL, Mumy KL, Murphy P, Lory S, McCormick BA.

Microbes Infect. 2010 Mar;12(3):190-8. doi: 10.1016/j.micinf.2009.11.009. Epub 2009 Dec 2.

39.

Analysis of acquisition of Pseudomonas aeruginosa gastrointestinal mucosal colonization and horizontal transmission in a murine model.

Kamei A, Koh AY, Gadjeva M, Priebe GP, Lory S, Pier GB.

J Infect Dis. 2010 Jan 1;201(1):71-80. doi: 10.1086/648616.

40.

Multiple activities of c-di-GMP in Pseudomonas aeruginosa.

Lory S, Merighi M, Hyodo M.

Nucleic Acids Symp Ser (Oxf). 2009;(53):51-2. doi: 10.1093/nass/nrp026.

PMID:
19749255
41.

Genome-wide study of Pseudomonas aeruginosa outer membrane protein immunogenicity using self-assembling protein microarrays.

Montor WR, Huang J, Hu Y, Hainsworth E, Lynch S, Kronish JW, Ordonez CL, Logvinenko T, Lory S, LaBaer J.

Infect Immun. 2009 Nov;77(11):4877-86. doi: 10.1128/IAI.00698-09. Epub 2009 Sep 8.

42.

Role of Horizontal Gene Transfer in the Evolution of Pseudomonas aeruginosa Virulence.

Qiu X, Kulasekara BR, Lory S.

Genome Dyn. 2009;6:126-39. doi: 10.1159/000235767. Epub 2009 Aug 19.

PMID:
19696498
43.

The GacS/GacA signal transduction system of Pseudomonas aeruginosa acts exclusively through its control over the transcription of the RsmY and RsmZ regulatory small RNAs.

Brencic A, McFarland KA, McManus HR, Castang S, Mogno I, Dove SL, Lory S.

Mol Microbiol. 2009 Aug;73(3):434-45. doi: 10.1111/j.1365-2958.2009.06782.x. Epub 2009 Jul 9.

44.

Determination of the regulon and identification of novel mRNA targets of Pseudomonas aeruginosa RsmA.

Brencic A, Lory S.

Mol Microbiol. 2009 May;72(3):612-32. doi: 10.1111/j.1365-2958.2009.06670.x.

45.

Direct interaction between sensor kinase proteins mediates acute and chronic disease phenotypes in a bacterial pathogen.

Goodman AL, Merighi M, Hyodo M, Ventre I, Filloux A, Lory S.

Genes Dev. 2009 Jan 15;23(2):249-59. doi: 10.1101/gad.1739009.

46.

The essential role of the CopN protein in Chlamydia pneumoniae intracellular growth.

Huang J, Lesser CF, Lory S.

Nature. 2008 Nov 6;456(7218):112-5. doi: 10.1038/nature07355. Epub 2008 Oct 1.

47.

Identification of small molecule inhibitors of Pseudomonas aeruginosa exoenzyme S using a yeast phenotypic screen.

Arnoldo A, Curak J, Kittanakom S, Chevelev I, Lee VT, Sahebol-Amri M, Koscik B, Ljuma L, Roy PJ, Bedalov A, Giaever G, Nislow C, Merrill AR, Lory S, Stagljar I.

PLoS Genet. 2008 Feb 29;4(2):e1000005. doi: 10.1371/journal.pgen.1000005. Erratum in: PLoS Genet. 2008 Apr;4(4). doi: 10.1371/annotation/76d35829-07a2-479f-bbc1-cce6755b6d8c. Merrill, Rod A [corrected to Merrill, A Rod].

48.

Dynamics of Pseudomonas aeruginosa genome evolution.

Mathee K, Narasimhan G, Valdes C, Qiu X, Matewish JM, Koehrsen M, Rokas A, Yandava CN, Engels R, Zeng E, Olavarietta R, Doud M, Smith RS, Montgomery P, White JR, Godfrey PA, Kodira C, Birren B, Galagan JE, Lory S.

Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3100-5. doi: 10.1073/pnas.0711982105. Epub 2008 Feb 19.

49.

A cyclic-di-GMP receptor required for bacterial exopolysaccharide production.

Lee VT, Matewish JM, Kessler JL, Hyodo M, Hayakawa Y, Lory S.

Mol Microbiol. 2007 Sep;65(6):1474-84.

50.

Supplemental Content

Support Center